Imatinib Mesylate Tablets are a type of oral medication classified as a targeted therapy, specifically a tyrosine kinase inhibitor. They are mainly used in the treatment of certain cancers and blood disorders.

Here are some important points about them:

• Appearance: Usually available as film-coated tablets in different strengths.

• Primary Use: Commonly prescribed for chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and some other cancers involving abnormal cell growth.

• Mechanism: They work by blocking abnormal proteins (tyrosine kinases) that drive cancer cell growth and division.

• Administration: Taken orally with water, often with food to reduce stomach irritation. Dosage depends on the condition and patient’s response.

• Common Side Effects: Nausea, vomiting, diarrhea, fluid retention, rash, muscle cramps, and fatigue.

• Serious Concerns: In some cases, liver issues, heart problems, low blood cell counts, or severe fluid retention may occur, requiring medical attention.

• Precautions: Patients with liver, kidney, or heart conditions need careful monitoring. Regular blood tests are recommended to check for safety and effectiveness.

• Storage: Generally stored at room temperature, away from moisture and direct sunlight.